The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
复制标题
DOI:
10.1038/sj.mp.4000350
复制
发表时间:
1998-05-01
影响因子:
11
通讯作者:
Hietala, J
中科院分区:
文献类型:
--
作者:
Pohjalainen, T;Rinne, JO;Hietala, J
Positron emission tomography (PET) studies have revealed significant interindividual variation in dopamine D-2 receptor density in vivo in human striatum.(1) Low D-2 receptor binding in vivo has been found to associate with alcohol/substance dependence,(2-6) It has been suggested that the Al allele of human D-2 receptor gene might be associated to a specific type of alcoholism(7) and possibly to a reduced D-2 receptor density in vitro.(8) We have determined D-2 dopamine receptor-binding density (B-max), affinity (K-d) and availability (B-max/K-d) in 54 healthy Finnish volunteers using PET and [C-11]raclopride in order to determine whether the A1 allele is associated with a 'baseline' difference in D-2 receptor characteristics in vivo. A statistically significant reduction in D-2 receptor availability reflecting an alteration in receptor density was observed in the A1/A2 genotype group compared to the A2/A2 group. There was no difference in apparent K-d between the two groups. In conclusion, the association between the A1 allele and low D-2 receptor availability in healthy subjects indicates that the A1 allele of the TaqIA polymorphism might be in linkage disequilibrium with a mutation in the promoter/regulatory gene element that affects dopamine D-2 receptor expression. This study provides an in vivo neurobiological correlate to the A1 allele in healthy volunteers.